{"nct_id":"NCT03283371","title":"Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy","status":"COMPLETED","status_verified_date":"2021-11","start_date":"2018-03-20","start_date_type":"ACTUAL","primary_completion_date":"2020-01-11","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BIIB"]}